Fairmount Funds Management LLC Point Biopharma Global Inc. Transaction History

Fairmount Funds Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$7.24 - $10.31 $7.24 Million - $10.3 Million	1,000,000 Added 54.53%	2,833,950 $21.9 Million
Q2 2022 Aug 15, 2022	SELL	$5.6 - $9.5 $2.68 Million - $4.55 Million	-478,573 Reduced 20.69%	1,833,950 $12.5 Million
Q1 2022 May 16, 2022	BUY	$5.46 - $8.13 $4.33 Million - $6.45 Million	793,141 Added 52.2%	2,312,523 $18.4 Million
Q4 2021 Feb 14, 2022	BUY	$4.83 - $9.75 $2.03 Million - $4.09 Million	419,893 Added 38.19%	1,519,382 $8.51 Million
Q3 2021 Nov 15, 2021	BUY	$7.42 - $11.26 $8.16 Million - $12.4 Million	1,099,489 New	1,099,489 $8.46 Million

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Fairmount Funds Management LLC, based on Form 13F filings with the SEC.

Stay updated on Fairmount Funds Management LLC with notifications on news.